Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: A longitudinal population-based study

Journal of Rheumatology

Volumn 39, Issue 7, 2012, Pages 1355-1362

  Myasoedova, Elena ^a,b   Matteson, Eric L ^a   Talley, Nicholas J ^c   Crowson, Cynthia S ^a  

^a Mayo Clinic College of Medicine   (United States)

^b IVANOVO STATE MEDICAL ACADEMY   (Russian Federation)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Gastrointestinal disease; Incidence; Rheumatoid Arthritis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR;

ABDOMINAL SURGERY; ADULT; ANAMNESIS; ARTICLE; COHORT ANALYSIS; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DISEASE ASSOCIATION; DIVERTICULITIS; DRUG EXPOSURE; DRUG INDUCED DISEASE; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGITIS; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL OBSTRUCTION; HUMAN; INCIDENCE; INFECTIOUS COLITIS; INTESTINAL BLEEDING; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; ISCHEMIC COLITIS; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SMOKING; TREND STUDY; ULCERATIVE COLITIS; UNITED STATES; UPPER GASTROINTESTINAL BLEEDING; UPPER GASTROINTESTINAL TRACT;

ABDOMEN; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; FEMALE; GASTROINTESTINAL DISEASES; GLUCOCORTICOIDS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MINNESOTA; RISK; SMOKING;

EID: 84863529243     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111311     Document Type: Article

References (43)

1. Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol 1999;26:2475-9. (Pubitemid 29528993)
2. Koivuniemi R, Paimela L, Suomalainen R, Piirainen H, Karesoja M, Helve T, et al. Causes of death in patients with rheumatoid arthritis autopsied during a 40-year period. Rheumatol Int 2008;28:1245-52.
3. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:885-906. (Pubitemid 47377810)
4. Mikuls TR. Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:729-52.
5. Schneider A, Merikhi A, Frank BB. Autoimmune disorders: Gastrointestinal manifestations and endoscopic findings. Gastrointest Endosc Clin N Am 2006;16:133-51.
6. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94. (Pubitemid 24115934)
7. Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005;100:1685-93. (Pubitemid 41648418)
8. Bannwarth B. Safety of the nonselective NSAID nabumetone: Focus on gastrointestinal tolerability. Drug Saf 2008;31:485-503. (Pubitemid 351693682)
9. Dijkmans BA, Janssen M, Vandenbroucke JP, Lamers CB. NSAID-associated upper gastrointestinal damage in patients with rheumatoid arthritis. Scand J Gastroenterol Suppl 1995;212:105-8.
10. Fries JF, Bruce B. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003;30:2226-33. (Pubitemid 37221856)
11. Goldstein JL, Eisen GM, Agrawal N, Stenson WF, Kent JD, Verburg KM. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib. Aliment Pharmacol Ther 2004;20:527-38. (Pubitemid 39243898)
12. Janssen M, Dijkmans BA, van der Sluys FA, van der Wielen JG, Havenga K, Vandenbroucke JP, et al. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol 1992;31:747-52.
13. Wolfe F, Hawley DJ. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: A prospective 13 year study of 2131 patients. J Rheumatol 2000;27:1668-73. (Pubitemid 30462809)
14. Fries JF, Murtagh KN, Bennett M, Zatarain E, Lingala B, Bruce B. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis. Arthritis Rheum 2004;50:2433-40. (Pubitemid 39062702)
15. Steen KS, Nurmohamed MT, Visman I, Heijerman M, Boers M, Dijkmans BA, et al. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:256-9. (Pubitemid 351183319)
16. Combe B, Swergold G, McLay J, McCarthy T, Zerbini C, Emery P, et al. Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). Rheumatology 2009;48:425-32.
17. Curtis JR, Xie F, Chen L, Spettell C, McMahan RM, Fernandes J, et al. The incidence of gastrointestinal perforations among rheumatoid arthritis patients. Arthritis Rheum 2011;63:346-51.
18. Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: Results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 2008;67:1516-23.
19. Gout T, Ostor AJ, Nisar MK. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: A systematic literature review. Clin Rheumatol 2011;30:1471-4.
20. Laine L, Curtis SP, Langman M, Jensen DM, Cryer B, Kaur A, et al. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology 2008;135:1517-25.
21. Laine L, Smith R, Min K, Chen C, Dubois RW. Systematic review: The lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006;24:751-67.
22. Maradit Kremers H, Crowson CS, Gabriel SE. Rochester Epidemiology Project: A unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004;30:819-34, vii. (Pubitemid 39361475)
23. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
24. Maradit Kremers H, Myasoedova E, Crowson CS, Savova G, Gabriel SE, Matteson EL. The Rochester Epidemiology Project: Exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology 2011;50:6-15.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
26. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: Prevalence and mortality. Rheumatology 1999;38:668-74. (Pubitemid 29507338)
27. Cox D. Some simple approximations for Poisson variates. Biometrika 1953;40:354-60.
28. McCullagh P, Nelder JA. Generalized linear models. New York: Chapman and Hall; 1989.
29. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: A population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8. (Pubitemid 36091647)
30. Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): A randomised trial. Lancet 2010;376:173-9.
31. Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: A meta-analysis. Ann Rheum Dis 2009;68:1833-8.
32. Hutchinson D, Lynch M. Sigmoid diverticular abscess perforation in 2 patients with rheumatoid arthritis treated with high dose corticosteroids. A cautionary tale. J Rheumatol 2001;28:1935-6. (Pubitemid 32726952)
33. Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003;124:288-92. (Pubitemid 36169245)
34. Mpofu S, Mpofu CM, Hutchinson D, Maier AE, Dodd SR, Moots RJ. Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions. Ann Rheum Dis 2004;63:588-90. (Pubitemid 38530206)
35. Myllykangas-Luosujarvi R. Diverticulosis - a primary cause of life-threatening complications in rheumatoid arthritis. Clin Exp Rheumatol 1995;13:79-82.
36. Matteson EL, Yachyshyn V, Yachyshyn J, O'Fallon WM. Trends in hospitalizations for gastrointestinal bleeding among patients with rheumatoid arthritis in Rochester, Minnesota, 1950-1991. J Rheumatol 1995;22:1471-7.
37. Lanas A. A review of the gastrointestinal safety data - A gastroenterologist's perspective. Rheumatology 2010;49 Suppl 2:ii3-10.
38. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009;104:1633-41.
39. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998;93:2037-46.
40. Decker D, Tolba R, Springer W, Lauschke H, Hirner A, von Ruecker A. Abdominal surgical interventions: Local and systemic consequences for the immune system - a prospective study on elective gastrointestinal surgery. J Surg Res 2005;126:12-8. (Pubitemid 40726240)
41. Russell RI. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy. Ital J Gastroenterol Hepatol 1999;31 Suppl 1:S14-8. (Pubitemid 29248580)
42. Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, Hoglund CO, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 2010; 181:1217-22.
43. King DE, Mainous AG 3rd, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med 2009;122:528-34.